Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease atrial fibrillation
Phenotype C0007194|hypertrophic cardiomyopathy
Sentences 25
PubMedID- 21515029 Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance.
PubMedID- 24103078 At 52 years of age, he was diagnosed with mid-ventricular obstructive hypertrophic cardiomyopathy (hcm) associated with paroxysmal atrial fibrillation.
PubMedID- 21514088 Successful electrical cardioversion in a massive concentric hypertrophic cardiomyopathy with atrial fibrillation.
PubMedID- 20079992 Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
PubMedID- 20154076 Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 20494669 Interactions between sleep disordered breathing and atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 25212378 An even lower la volume of ≥27 ml/m2 has been reported as being predictive of future atrial fibrillation in patients with hypertrophic cardiomyopathy [24].
PubMedID- 24097220 Prevalent atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm) represents an important issue with regard to stroke events caused by embolization and is associated with high mortality.
PubMedID- 25739859 Qtc interval prolongation predicts arrhythmia recurrence after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24114776 Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence.
PubMedID- 23348529 Background: atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm) is generally associated with deterioration of the clinical status, functional capacity, and quality of life.
PubMedID- 21684113 Background: in addition to sudden death, heart failure and stroke due to atrial fibrillation are important in patients with hypertrophic cardiomyopathy (hcm).
PubMedID- 26493159 Predictors of future atrial fibrillation development in patients with hypertrophic cardiomyopathy: a prospective follow-up study.
PubMedID- 24763706 Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24280311 Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 26302740 Purpose: the primary aim of this systematic review was to assess the efficacy of catheter ablation of atrial fibrillation (af) in patients with hypertrophic cardiomyopathy (hcm).
PubMedID- 24014282 atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.
PubMedID- 24217781 Avoid atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24599807 Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 25452101 Impact of left ventricular diastolic dysfunction on outcome of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24326897 Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 25814420 Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
PubMedID- 24965028 atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.
PubMedID- 20173211 Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
PubMedID- 25857916 atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors.

Page: 1